Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurelien Amiot

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|April 29, 2020
Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroidsRobert Salameh, Julien Kirchgesner, Matthieu Allez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 15, 2012
Long-term outcome after extensive intestinal resection for chronic radiation enteritisAurelien Amiot, Francisca Joly, Jérémie H Lefevre, et al.
Clinics and Research in Hepatology and Gastroenterology|October 1, 2025
Effectiveness and safety of third-line advanced therapies in patients with ulcerative colitis: A multicentre retrospective cohort study: Third-line treatment in UCAnaïs Bertrand, Antoine Meyer, Julien Kirchgesner, et al.
The American Journal of Surgical Pathology|March 3, 2009
The role of immunohistochemistry in idiopathic chronic intestinal pseudoobstruction (CIPO): a case-control studyAurelien Amiot, Dominique Cazals-Hatem, Francisca Joly, et al.
Therapeutic Advances in Gastroenterology|May 2, 2013
Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?Iradj Sobhani, Aurelien Amiot, Yann Le Baleur, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2019
Patients' perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort studyNicolas Petitdidier, Jenny Tannoury, Nicola de'Angelis, et al.
Digestive Diseases and Sciences|November 18, 2016
Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort StudyCaroline Prieux-Klotz, Stéphane Nahon, Aurelien Amiot, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2014
Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective studyArmelle Chauvin, Aurelie Le Thuaut, Mehdi Belhassan, et al.
Clinics and Research in Hepatology and Gastroenterology|November 19, 2023
Gastric microbiota in patients with gastric MALT lymphoma according to Helicobacter pylori infectionAntoine Martin, Marine Jauvain, Emma Bergsten, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 22, 2011
High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphomaAurelien Amiot, Matthieu Allez, Xavier Treton, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|April 29, 2020
Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroidsRobert Salameh, Julien Kirchgesner, Matthieu Allez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 15, 2012
Long-term outcome after extensive intestinal resection for chronic radiation enteritisAurelien Amiot, Francisca Joly, Jérémie H Lefevre, et al.
Clinics and Research in Hepatology and Gastroenterology|October 1, 2025
Effectiveness and safety of third-line advanced therapies in patients with ulcerative colitis: A multicentre retrospective cohort study: Third-line treatment in UCAnaïs Bertrand, Antoine Meyer, Julien Kirchgesner, et al.
The American Journal of Surgical Pathology|March 3, 2009
The role of immunohistochemistry in idiopathic chronic intestinal pseudoobstruction (CIPO): a case-control studyAurelien Amiot, Dominique Cazals-Hatem, Francisca Joly, et al.
Therapeutic Advances in Gastroenterology|May 2, 2013
Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?Iradj Sobhani, Aurelien Amiot, Yann Le Baleur, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2019
Patients' perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort studyNicolas Petitdidier, Jenny Tannoury, Nicola de'Angelis, et al.
Digestive Diseases and Sciences|November 18, 2016
Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort StudyCaroline Prieux-Klotz, Stéphane Nahon, Aurelien Amiot, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2014
Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective studyArmelle Chauvin, Aurelie Le Thuaut, Mehdi Belhassan, et al.
Clinics and Research in Hepatology and Gastroenterology|November 19, 2023
Gastric microbiota in patients with gastric MALT lymphoma according to Helicobacter pylori infectionAntoine Martin, Marine Jauvain, Emma Bergsten, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 22, 2011
High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphomaAurelien Amiot, Matthieu Allez, Xavier Treton, et al.
Pageof 8